Displaying 81 - 100 of 163
FTC Refunds More Than $110,000 to Consumers Who Bought StimTein Joint Pain Relief Pills
FTC Refunds Almost $3.9 Million to Purchasers of Deceptively Advertised Quell Wearable Pain-Relief Device
FTC and State of Wisconsin Warn Hearing Aid Sellers About Deceptive Stimulus Payment Claims
Zaappaaz LLC
The Federal Trade Commission filed suit against Zaappaaz, the operators of wrist-band.com and other online storefronts, for failing to deliver on promises that they could quickly ship products like face masks, sanitizer, and other personal protective equipment (PPE) related to the coronavirus pandemic.
The lawsuit alleges that the company violated the FTC’s Mail, Internet and Telephone Order Rule (Mail Order Rule), which requires that companies notify consumers of shipping delays in a timely manner and give consumers the chance to cancel orders and receive prompt refunds.
FTC Order Stops the Marketer of “Thrive” Supplement from Making Baseless Claims It Can Treat, Prevent, or Reduce the Risks from COVID-19
FTC Sending Refund Checks Totaling Almost $149,000 to Consumers Who Bought ReJuvenation “Anti-Aging” Pill
FTC Sending Refund Checks Totaling More Than $470,000 to Consumers Defrauded by Misleading Health Claims for TrueAloe and AloeCran Supplements
FTC Sends Letters Warning 50 More Marketers to Stop Making Unsupported Claims That Their Products and Therapies Can Effectively Prevent or Treat COVID-19
FTC Alerts Consumers About Nursing Homes and Assisted Living Facilities Taking Stimulus Checks From Medicaid Patients
“Thrive” Supplement Marketer Agrees to Preliminary Order Barring Him from Claiming It Can Treat, Prevent, or Reduce the Risks Associated with COVID-19
Health Center, Inc. Settles FTC Allegations That It Targeted Older Consumers With Deceptive Claims for Health and Wellness Products
Tea Marketer Misled Consumers, Didn’t Adequately Disclose Payments to Well-Known Influencers, FTC Alleges
Statement of the Commission in the Matter of Teami, LLC
Marketers of Pain Relief Device Settle FTC False Advertising Complaint
FTC Sues Publisher for Targeting Seniors With Phony Diabetes Cure and Money Making Schemes
FTC Obtains Preliminary Injunction Halting Online Beauty Product Sellers’ Deceptive “Free Trial” Offers
Nobetes Corp.
In December 2018, officers of a company that marketed and sold Nobetes, a pill they claimed treats diabetes, settled an FTC complaint alleging that the advertising claims for the product are false or unsubstantiated. The order settling the FTC’s complaint prohibits the company and its officers from undertaking future deceptive practices, including making unsubstantiated health claims, misleading consumers about the terms of “free trial” offers, billing consumers without their consent, and other practices related to the use of “expert” endorsements and consumer testimonials. In addition, it requires them to pay money to provide refunds to consumers who bought the product. In August 2019, the FTC returned $60,791 to these consumers.
Derek Jason Bartoli
Announced in June 2019 as part of a crackdown on illegal robocalls against operations around the country responsible for more than one billion calls, the FTC’s complaint against Derek Jason Bartoli alleges the Florida-based defendant has been an active participant in the illegal telemarketing industry for several years, serving as the “dialer,” “information technology (IT) guy,” and at times the seller for various telemarketing companies, including companies that the FTC and other law enforcement agencies have sued. He provided services in his own name and in the names of Phoenix Innovative Solutions LLC, Marketing Consultation Solutions LLC, and KimRain Marketing LLC.
Displaying 81 - 100 of 163